陳志明  博士

Dr. Balance Chen 

我們以研究並推廣人類因為慢性缺氧問題,所引發的諸多慢性疾病為努力目標

 聯 絡 我 們 

社群及版權宣告

本網站及旗下網站內容版權屬本中心所有,未經同意,盜載必究

Please reload

Recent Posts

對所有女性疾病中,最難以治療的疾病就以子宮肌腺症莫屬,由於它是生長在子宮肌肉內層的良性腫瘤,但對於想要保留子宮又希望能減少痛楚的女性來說,常常是魚與熊掌不能兼得的事。

子宮肌腺症是所有女性疾病當中最難纏的一種疾病,也是最容易影響生育的一種子宮內膜異位症,它的發生原因和其他的子宮內膜異位症其實是相同的,...

難纏但卻可以預防的子宮肌腺症問題

January 11, 2018

1/10
Please reload

Featured Posts

高血壓國際文獻

A Randomized, Double‐blind, Placebo‐controlled Study to Evaluate the Efficacy and Tolerability of Fufang Danshen (Salvia miltiorrhiza) as Add‐on Antihypertensive Therapy in Taiwanese Patients with Uncontrolled Hypertension

 

Hypertension generally requires the use of a combination therapy to achieve the satisfactory control of blood pressure. A traditional Chinese herb, Danshen (Salvia miltiorrhiza), has been shown to have cardioprotective effects in animals and humans. The study investigated the add‐on effect of Fufang Danshen extract capsule in Taiwanese hypertensive patients with uncontrolled blood pressure. This was a double‐blind, placebo‐controlled, randomized, single‐center study clinical trial. Fifty‐five patients with uncontrolled mild to moderate hypertension were enrolled under current conventional antihypertensive treatment, randomized equally to receive a Fufang Danshen capsule (formula mixture) 1000mg twice‐daily or a placebo capsule for 12weeks. Primary endpoints were the control rate and the response rate. By ITT analysis at week 12, the control rates were 25.5% in the Fufang Danshen group and 7.3% in the control group (p = 0.016). The response rates were 45.6% in the Fufang Danshen group and 38.2% in the placebo group (p = 0.946). A significant reduction of systolic blood pressure at week 12 was noted in the Fufang Danshen group compared with the placebo group (13.8 vs 4.2mmHg, p=0.005). A decrease of pulse rate was also noted in the Fufang Danshen group (− 3.2 vs +2.7/min, p = 0.027). Adverse events were not statistically different between the two groups. It was concluded that Fufang Danshen (Salvia miltiorrhiza) extract reduced systolic blood pressure and pulse rate, and was well tolerated in patients with
hypertension. Copyright © 2011 John Wiley & Sons, Ltd.

Share on Facebook
Share on Twitter
Please reload

Follow Us

I'm busy working on my blog posts. Watch this space!

Please reload

Search By Tags
Please reload

Archive
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square